Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 5,412 | 9,988 | 2,255 | 2,370 | 4,257 |
| Gross Profit | 6,140 | 9,980 | 2,250 | 2,360 | 4,160 |
| Operating Expenses | 7,420 | 6,920 | 6,300 | 6,660 | 6,500 |
| Operating Income | -2,008 | 3,068 | -4,045 | -4,290 | -2,243 |
| Other Income | 6,428 | -5,648 | -45 | 50 | -177 |
| Pre-tax Income | 4,420 | -2,580 | -4,090 | -4,240 | -2,420 |
| Net Income Continuous | -721 | -2,582 | -4,100 | -4,245 | -2,459 |
| Net Income | $-721 | $-2,582 | $-4,100 | $-4,245 | $-2,459 |
| EPS Basic Total Ops | -0.08 | -0.25 | -0.08 | -0.09 | -0.05 |
| EPS Basic Continuous Ops | -0.08 | -0.25 | -0.08 | -0.09 | -0.05 |
| EPS Diluted Total Ops | -0.08 | -0.25 | -0.08 | -0.09 | -0.05 |
| EPS Diluted Continuous Ops | -0.08 | -0.25 | -0.08 | -0.09 | -0.05 |
| EBITDA(a) | $-3,508 | $3,538 | $-3,485 | $-3,820 | $-1,843 |